참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | 5'-Atp | HCID 5957 | — |
| 반응물 | Tromethamine hydrochloride | HCID 93573 | — |
| 반응물 | Calcium Chloride | HCID 5284359 | — |
| 반응물 | 1-(3,5-Dimethoxy-4-hydroxyphenyl)-7-phenyl-1-heptene-3-one | HCID 53680764 | — |
| 생성물 | 5-Hydroxyicosa-6,8,11,14-tetraenoic acid | HCID 1771 | — |
반응 단계
76 μl of 50 mM Tris-HCl buffer (pH 7.4) containing 2.56 mM of CaCl2 and 2.56 mM of ATP and 20 μl of 5-lipoxygenase sample prepared above were added to 2μl of a solution containing a prescribed amount of the diarylheptanoide derivative (1) prepared in Example 1 in DSMO. The mixture was incubated at 37° C. After 15 minutes, the reaction was terminated with the addition of 200 μl of a 145:55:0.1 mixture of acetonitrile, methanol, and acetic acid. The reaction mixture was centrifuged (1300 rpm, 30 min., 40° C.). The amount of 5-HETE in the supernatant was measured by HPLC (column: Nova-pak 5C18; eluant: a 60:40 acetonitrile:0.05 M KH2PO4 solution with 5 mM trihexyl bromide added; flow rate: 0.8 ml/min.; wavelength: 235 nm). The amount of 5-HETE produced was calculated from the peak area of the 5-HETE. This procedure was repeated twice to determine the 5-lipoxygenase inhibiting activity of the diarylheptanoide derivative (1) from the average production amount of 5-HETE. The results are shown in FIG. 1, which indicates the 5-lipoxygenase inhibiting activity of the diarylheptanoide derivative (1).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US05763673 |
|---|
| 출처 데이터셋 | uspto-grants-1998_06 |
|---|
| ORD ID | ord-4b90922aaa1a462ab742f0d0c839c61b |
|---|
| 출처 메모 | uspto-grants-1998_06 |
|---|